Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2065841000168110 | ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2065851000168112 | ropivacaine hydrochloride 75 mg/10 mL injection, ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Is a | ropivacaine | true | Inferred relationship | Some | ||
| ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | has unit of use | ampoule | true | Inferred relationship | Some | 1154698237 | |
| ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | has intended active ingredient | ropivacaine | true | Inferred relationship | Some | 1154698236 | |
| ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | has Australian BoSS | ropivacaine hydrochloride | true | Inferred relationship | Some | 1154698236 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ropibam 0.75% 75 mg/10 mL injection, 10 mL ampoule | Is a | True | ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Inferred relationship | Some | |
| Ropivacaine (Sandoz) 75 mg/10 mL injection, 10 mL ampoule | Is a | True | ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Inferred relationship | Some | |
| Naropin 0.75% 75 mg/10 mL injection, 10 mL ampoule | Is a | True | ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Inferred relationship | Some | |
| ropivacaine hydrochloride 75 mg/10 mL injection, 5 x 10 mL ampoules | has MPUU | True | ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Inferred relationship | Some | 1 |
| Ropivacaine 0.75% (Actavis) 75 mg/10 mL injection, 10 mL ampoule | Is a | True | ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Inferred relationship | Some | |
| Ropivacaine 0.75% (Kabi) 75 mg/10 mL injection, 10 mL ampoule | Is a | True | ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR